- Home
- Publications
- Publication Search
- Publication Details
Title
The optimal immunosuppressive therapy for aplastic anemia
Authors
Keywords
Aplastic anemia, Immunosuppressive treatment, Anti-thymocyte globulin
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 97, Issue 5, Pages 564-572
Publisher
Springer Nature
Online
2013-04-18
DOI
10.1007/s12185-013-1331-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
- (2012) J. C. Marsh et al. BLOOD
- How I treat acquired aplastic anemia
- (2012) P. Scheinberg et al. BLOOD
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
- (2012) Matthew J. Olnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
- (2011) P. Scheinberg et al. BLOOD
- A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation
- (2011) A. Tichelli et al. BLOOD
- Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia
- (2011) T. Katagiri et al. BLOOD
- Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia
- (2011) M. G. Afable et al. HAEMATOLOGICA
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
- (2011) Phillip Scheinberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Congenital amegakaryocytic thrombocytopenia
- (2011) Amy E. Geddis PEDIATRIC BLOOD & CANCER
- Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study
- (2010) Elias Hallack Atta et al. ANNALS OF HEMATOLOGY
- Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going
- (2010) Antonio M. Risitano BRITISH JOURNAL OF HAEMATOLOGY
- Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia
- (2010) Phillip Scheinberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up
- (2009) R. A. Brodsky et al. BLOOD
- Guidelines for the diagnosis and management of aplastic anaemia
- (2009) Judith C. W. Marsh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA
- (2009) Antonio Maria Risitano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
- (2009) P. Scheinberg et al. HAEMATOLOGICA
- Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen
- (2009) S. Maury et al. HAEMATOLOGICA
- Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
- (2008) Phillip Scheinberg et al. BRITISH JOURNAL OF HAEMATOLOGY
- A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
- (2008) Hawk Kim et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation